4 - 10 February 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Cladribine and atrophy
Results of an analysis of the data from a previous study of cladribine, a potential disease modifying treatment for relapsing MS, suggests that over two years it is more effective that placebo at reducing the rate of brain tissue loss (atrophy) and disease progression
Source: Merck press release
MS Trust link: Cladribine
Blood test for MS type
Australian researchers have developed a blood test that will indicated which type of MS someone has with 85-90% accuracy and possibly the effectiveness of disease modifying drugs. They hope to develop a blood test kit that could be available "within as little as two years"
MS Trust link: Types of MS